Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
We Are Available 24/ 7. Call Now.
Morgan Stanley Maintains Royalty Pharma (RPRX) Overweight Recommendation
Fintel reports that on April 10, 2023, Morgan Stanley maintained coverage of Royalty Pharma (NASDAQ:RPRX) with a Overweight recommendation. Analyst Price Forecast Suggests 48.83% Upside